Therapeutic effectiveness of intratympanic and retroauricular methylprednisolone sodium succinate for refractory sudden sensorineural hearing loss in diabetic patients

doi:10.4239/wjd.v16.i5.99576

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (575)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

269

Figures (1-5)

109

Tables (1-3)

Sum=482

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=66

May 15, 2025 (publication date) through Jun 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. May 15, 2025; 16(5): 99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576

Full Size Figure Download Figure

Figure 3 Hearing thresholds at different frequencies in two groups. A: The hearing threshold at 250 Hz in both groups; B: The hearing threshold at 500 Hz in both groups; C: The hearing threshold at 1000 Hz in both groups. ^aP < 0.05, ^bP < 0.01 in the inter-group comparison.

Citation: Li D, Qiao F, Dai J, Xu M, Gong HY, Yang HM, Li JC, Huai D. Therapeutic effectiveness of intratympanic and retroauricular methylprednisolone sodium succinate for refractory sudden sensorineural hearing loss in diabetic patients. World J Diabetes 2025; 16(5): 99576
URL: https://www.wjgnet.com/1948-9358/full/v16/i5/99576.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i5.99576